Inhibitory machinery for the TGF-β family signaling pathway

References

• Alarcón C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S, Barlas A, Miller AN, Manova-Todorova K, Macias MJ, Sapkota G, Pan D, Massagué J. 2009. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell. 139:757–769.
   PubMed Web of Science ®Google Scholar
• Bai Y, Yang C, Hu K, Elly C, Liu YC. 2004. Itch E3 ligase-mediated regulation of TGF-β signaling by modulating Smad2 phosphorylation. Mol Cell. 15:825–831.
   PubMed Web of Science ®Google Scholar
• Barroso-delJesus A, Lucena-Aguilar G, Sanchez L, Ligero G, Gutierrez-Aranda I, Menendez P. 2011. The Nodal inhibitor Lefty is negatively modulated by the microRNA miR-302 in human embryonic stem cells. FASEB J. 25:1497–1508.
   Google Scholar
• Bennett D, Alphey L. 2002. PP1 binds Sara and negatively regulates Dpp signaling in Drosophila melanogaster. Nat Genet. 31:419–423.
   PubMed Web of Science ®Google Scholar
• Choi WY, Giraldez AJ, Schier AF. 2007. Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science. 318:271–274.
   PubMed Web of Science ®Google Scholar
• Conery AR, Cao Y, Thompson EA, Townsend CMJr, Ko TC, Luo K. 2004. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β induced apoptosis. Nat Cell Biol. 6:366–372.
   PubMed Web of Science ®Google Scholar
• Dai F, Lin X, Chang C, Feng X-H. 2009. Nuclear export of Smad2 and Smad3 by RanBP3 facilitates termination of TGF-β signaling. Dev Cell. 16:345–357.
   PubMed Web of Science ®Google Scholar
• Datta PK, Moses HL. 2000. STRAP and Smad7 synergize in the inhibition of transforming growth factor β signaling. Mol Cell Biol. 20:3157–3167.
   PubMed Web of Science ®Google Scholar
• Davis BN, Hilyard AC, Lagna G, Hata A. 2008. SMAD proteins control DROSHA-mediated microRNA maturation. Nature. 454:56–61.
   PubMed Web of Science ®Google Scholar
• Duan X, Liang Y-Y, Feng X-H, Lin X. 2006. Protein serine/threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway. J Biol Chem. 281:36526–36532.
   PubMed Web of Science ®Google Scholar
• Dupont S, Zacchigna L, Cordenonsi M, Soligo S, Adorno M, Rugge M, Piccolo S. 2005. Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell. 121:87–99.
   PubMed Web of Science ®Google Scholar
• Dupont S, Mamidi A, Cordenonsi M, Montagner M, Zacchigna L, Adorno M, Martello G, Stinchfield MJ, Soligo S, Morsut L, Inui M, Moro S, Modena N, Argenton F, Newfeld SJ, Piccolo S. 2009. FAM/USP9x, a deubiquitinating enzyme essential for TGFβ signaling, controls Smad4 monoubiquitination. Cell. 136:123–135.
   PubMed Web of Science ®Google Scholar
• Gao S, Alarcón C, Sapkota G, Rahman S, Chen PY, Goerner N, Macias MJ, Erdjument-Bromage H, Tempst P, Massagué J. 2009. Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-β signaling. Mol Cell. 36:457–468.
   PubMed Web of Science ®Google Scholar
• Gomis RR, Alarcón C, Nadal C, van Poznak C, Massagué J. 2006. C/EBPβ at the core of the TGFβ cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell. 10:203–214.
   PubMed Web of Science ®Google Scholar
• Guo X, Ramirez A, Waddell DS, Li Z, Liu X, Wang X-F. 2008. Axin and GSK3-b control Smad3 protein stability and modulate TGF-β signaling. Genes Dev. 22:106–120.
   PubMed Web of Science ®Google Scholar
• Gupta A, Gartner JJ, Sethupathy P, Hatzigeorgiou AG, Fraser NW. 2006. Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature. 442:82–85.
   PubMed Web of Science ®Google Scholar
• Hagihara M, Endo M, Hata K, Higuchi C, Takaoka K, Yoshikawa H, Yamashita T. 2010. Neogenin, a receptor for bone morphogenetic proteins. J Biol Chem. 286:5157–5165.
   Google Scholar
• Hao J, Zhang S, Zhou Y, Hu X, Shao C. MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. FEBS Lett. 2011a; 585:207–213.
   Web of Science ®Google Scholar
• Hao J, Zhang S, Zhou Y, Liu C, Hu X, Shao C. MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochem Biophys Res Commun. 2011b; 406:552–557.
   PubMed Web of Science ®Google Scholar
• Hata A, Lagna G, Massagué J, Hemmati-Brivanlou A. 1998. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 12:186–197.
   PubMedGoogle Scholar
• Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MAJr, Wrana JL, Falb D. 1997. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell. 89:1165–1173.
   PubMed Web of Science ®Google Scholar
• He W, Dorn DC, Erdjument-Bromage H, Tempst P, Moore MA, Massagué J. 2006. Hematopoiesis controlled by distinct TIF1γ and Smad4 branches of the TGFβ pathway. Cell. 125:929–941.
   PubMed Web of Science ®Google Scholar
• Heikkinen PT, Nummela M, Leivonen SK, Westermarck J, Hill CS, Kähäri VM, Jaakkola PM. 2010. Hypoxia-activated Smad3-specific dephosphorylation by PP2A. J Biol Chem. 285:3740–3749.
   PubMed Web of Science ®Google Scholar
• Hesling C, Fattet L, Teyre G, Jury D, Gonzalo P, Lopez J, Vanbelle C, Morel AP, Gillet G, Mikaelian I, Rimokh R. Antagonistic regulation of EMT by TIF1γ and Smad4 in mammary epithelial cells. EMBO Rep. 2011 in press.
   Google Scholar
• Iemura S, Yamamoto TS, Takagi C, Uchiyama H, Natsume T, Shimasaki S, Sugino H, Ueno N. 1998. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci U S A. 95:9337–9342.
   PubMed Web of Science ®Google Scholar
• Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Miyazono K. 1997. Smad6 inhibits signalling by the TGF-β superfamily. Nature. 389:622–626.
   PubMed Web of Science ®Google Scholar
• Ishisaki A, Yamato K, Hashimoto S, Nakao A, Tamaki K, Nonaka K, ten Dijke P, Sugino H, Nishihara T. 1999. Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells. J Biol Chem. 274:13637–13642.
   PubMedGoogle Scholar
• Itoh S, ten Dijke P. 2007. Negative regulation of TGF-β receptor/Smad signal transduction. Curr Opin Cell Biol. 19:176–184.
   PubMed Web of Science ®Google Scholar
• Itoh S, Thorikay M, Kowanetz M, Moustakas A, Itoh F, Heldin C-H, ten Dijke P. 2003. Elucidation of Smad requirement in transforming growth factor-β type I receptor-induced responses. J Biol Chem. 278:3751–3761.
   PubMed Web of Science ®Google Scholar
• Izzi L, Attisano L. 2004. Regulation of the TGFβ signaling pathway by ubiquitin-mediated degradation. Oncogene. 23:2071–2078.
   PubMed Web of Science ®Google Scholar
• Jin W, Kim B-C, Tognon C, Lee H-J, Patel S, Lannon CL, Maris JM, Triche TJ, Sorensen PH, Kim S-J. 2005. The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-β signaling by inactivating the TGF-β type II receptor. Proc Natl Acad Sci U S A. 102:16239–16244.
   Google Scholar
• Kang JS, Liu C, Derynck R. 2009. New regulatory mechanisms of TGF-β receptor function. Trends Cell Biol. 19:385–394.
   PubMed Web of Science ®Google Scholar
• Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Wrana JL. 2000. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation. Mol Cell. 6:1365–1375.
   PubMed Web of Science ®Google Scholar
• Kim BC, Lee HJ, Park SH, Lee SR, Karpova TS, McNally JG, Felici A, Lee DK, Kim SJ. 2004. Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor β signaling by binding to Smad7 and promoting its degradation. Mol Cell Biol. 24:2251–2262.
   PubMed Web of Science ®Google Scholar
• Knockaert M, Sapkota G, Alarcón C, Massagué J, Brivanlou AH. 2006. Unique players in the BMP pathway: Small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling. Proc Natl Acad Sci U S A. 103:11940–11945.
   Google Scholar
• Koinuma D, Shinozaki M, Komuro A, Goto K, Saitoh M, Hanyu A, Ebina M, Nukiwa T, Miyazawa K, Imamura T, Miyazono K. 2003. Arkadia amplifies TGF-β superfamily signalling through degradation of Smad7. EMBO J. 22:6458–6470.
   PubMed Web of Science ®Google Scholar
• Komuro A, Imamura T, Saitoh M, Yoshida Y, Yamori T, Miyazono K, Miyazawa K. 2004. Negative regulation of transforming growth factor-β (TGF-β) signaling by WW domain-containing protein 1 (WWP1). Oncogene. 23:6914–6923.
   PubMed Web of Science ®Google Scholar
• Kowanetz M, Lönn P, Vanlandewijck M, Kowanetz K, Heldin C-H, Moustakas A. 2008. TGFβ induces SIK to negatively regulate type I receptor kinase signaling. J Cell Biol. 182:655–662.
   PubMed Web of Science ®Google Scholar
• Krause C, Korchynskyi O, de Rooij K, Weidauer SE, de Gorter DJ, van Bezooijen RL, Hatsell S, Economides AN, Mueller TD, Löwik CW, ten Dijke P. 2010. Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways. J Biol Chem. 285:41614–41626.
   PubMed Web of Science ®Google Scholar
• Kuratomi G, Komuro A, Goto K, Shinozaki M, Miyazawa K, Miyazono K, Imamura T. 2005. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-β (transforming growth factor-β) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-β type I receptor. Biochem J. 386:461–470.
   PubMed Web of Science ®Google Scholar
• Lallemand F, Seo SR, Ferrand N, Pessah M, L'Hoste S, Rawadi G, Roman–Roman S, Camonis J, Atfi A. 2005. AIP4 restricts transforming growth factor-β signaling through a ubiquitination-independent mechanism. J Biol Chem. 280:27645–27653.
   PubMed Web of Science ®Google Scholar
• Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, Maegdefessel L, Kundu RK, Quertermous T, Tsao PS, Spin JM. 2011. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol. 226:1035–1043.
   Google Scholar
• Li J, Li WX. 2006. A novel function of Drosophila elF4A as a negative regulator of Dpp/BMP signaling that mediates SMAD degradation. Nat Cell Biol. 8:1407–1414.
   PubMedGoogle Scholar
• Li L, Xin H, Xu X, Huang M, Zhang X, Chen Y, Zhang S, Fu X-Y, Chang Z. 2004. CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription. Mol Cell Biol. 24:856–864.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE, Wu D. 2005. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem. 280:19883–19887.
   PubMed Web of Science ®Google Scholar
• Li Z, Hassan MQ, Volinia S, van Wijnen AJ, Stein JL, Croce CM, Lian JB, Stein GS. 2008. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A. 105:13906–13911.
   PubMed Web of Science ®Google Scholar
• Li Z, Yang CS, Nakashima K, Rana TM. 2011. Small RNA-mediated regulation of iPS cell generation. EMBO J. 30:823–834.
   PubMed Web of Science ®Google Scholar
• Liang M, Liang Y-Y, Wrighton K, Ungermannova D, Wang X-P, Brunicardi FC, Liu X, Feng X-H, Lin X. 2004. Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2. Mol Cell Biol. 24:7524–7537.
   PubMed Web of Science ®Google Scholar
• Lin HK, Bergmann S, Pandolfi PP. 2004. Cytoplasmic PML function in TGF-β signalling. Nature. 431:205–211.
   PubMed Web of Science ®Google Scholar
• Lin F, Morrison JM, Wu W, Worman HJ. 2005. MAN1, an integral protein of the inner nuclear membrane, binds Smad2 and Smad3 and antagonizes transforming growth factor-β signaling. Hum Mol Genet. 14:437–445.
   PubMed Web of Science ®Google Scholar
• Lin X, Duan X, Liang Y-Y, Su Y, Wrighton KH, Long J, Hu M, Davis CM, Wang J, Brunicardi FC, Shi Y, Chen Y-G, Meng A, Feng X-H. 2006. PPM1A functions as a Smad phosphatase to terminate TGFβ signaling. Cell. 125:915–928.
   PubMed Web of Science ®Google Scholar
• Lin EA, Kong L, Bai XH, Luan Y, Liu CJ. 2009. miR-199a, a bone morphogenic protein 2-responsive microRNA, regulates chondrogenesis via direct targeting to Smad1. J Biol Chem. 284:11326–11335.
   PubMed Web of Science ®Google Scholar
• Liu W, Rui H, Wang J, Lin S, He Y, Chen M, Li Q, Ye Z, Zhang S, Chan SC, Chen YG, Han J, Lin SC. 2006. Axin is a scaffold protein in TGF-β signaling that promotes degradation of Smad7 by Arkadia. EMBO J. 25:1646–1658.
   PubMed Web of Science ®Google Scholar
• Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminski N, Abraham E. 2010. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med. 207:1589–1597.
   PubMed Web of Science ®Google Scholar
• Liu R, Zhou Z, Huang J, Chen C. 2011. PMEPA1 promotes androgen receptor-negative prostate cell proliferation through suppressing the Smad3/4-c-Myc-p21 Cip1 signaling pathway. J Pathol. 223:683–694.
   Google Scholar
• Lo SS, Hung PS, Chen JH, Tu HF, Fang WL, Chen CY, Chen WT, Gong NR, Wu CW. Overexpression of miR-370 and downregulation of its novel target TGFβ-RII contribute to the progression of gastric carcinoma. Oncogene. 2011 in press.
   Google Scholar
• Lönn P, van der Heide LP, Dahl M, Hellman U, Heldin CH, Moustakas A. 2010. PARP-1 attenuates Smad-mediated transcription. Mol Cell. 40:521–532.
   PubMed Web of Science ®Google Scholar
• Louafi F, Martinez-Nunez RT, Sanchez-Elsner T. 2010. MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-β. J Biol Chem. 285:41328–41336.
   PubMed Web of Science ®Google Scholar
• Luo K, Stroschein SL, Wang W, Chen D, Martens E, Zhou S, Zhou Q. 1999. The Ski oncoprotein interacts with the Smad proteins to repress TGFβ signaling. Genes Dev. 13:2196–2206.
   PubMed Web of Science ®Google Scholar
• Luzi E, Marini F, Sala SC, Tognarini I, Galli G, Brandi ML. 2008. Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res. 23:287–295.
   PubMed Web of Science ®Google Scholar
• Martello G, Zacchigna L, Inui M, Montagner M, Adorno M, Mamidi A, Morsut L, Soligo S, Tran U, Dupont S, Cordenonsi M, Wessely O, Piccolo S. 2007. MicroRNA control of Nodal signalling. Nature. 449:183–188.
   PubMed Web of Science ®Google Scholar
• Massagué J. 2008. TGFβ in cancer. Cell. 134:215–230.
   PubMed Web of Science ®Google Scholar
• Melhuish TA, Wotton D. 2000. The interaction of the carboxyl terminus-binding protein with the Smad corepressor TGIF is disrupted by a holoprosencephaly mutation in TGIF. J Biol Chem. 275:39762–39766.
   PubMed Web of Science ®Google Scholar
• Mestdagh P, Boström AK, Impens F, Fredlund E, Van Peer G, De Antonellis P, von Stedingk K, Ghesquière B, Schulte S, Dews M, Thomas-Tikhonenko A, Schulte JH, Zollo M, Schramm A, Gevaert K, Axelson H, Speleman F, Vandesompele J. 2010. The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma. Mol Cell. 40:762–773.
   PubMed Web of Science ®Google Scholar
• Mizuno Y, Tokuzawa Y, Ninomiya Y, Yagi K, Yatsuka-Kanesaki Y, Suda T, Fukuda T, Katagiri T, Kondoh Y, Amemiya T, Tashiro H, Okazaki Y. 2009. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett. 583:2263–2268.
   PubMed Web of Science ®Google Scholar
• Morén A, Imamura T, Miyazono K, Heldin C-H, Moustakas A. 2005. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J Biol Chem. 280:22115–22123.
   PubMed Web of Science ®Google Scholar
• Morén A, Raja E, Heldin C-H, Moustakas A. 2011. Negative regulation of TGFβ signaling by the kinase LKB1 and the scaffolding protein LIP1. J Biol Chem. 286:341–353.
   Google Scholar
• Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H. 1990. Activin-binding protein from rat ovary is follistatin. Science. 247:836–838.
   PubMed Web of Science ®Google Scholar
• Nakano A, Koinuma D, Miyazawa K, Uchida T, Saitoh M, Kawabata M, Hanai J, Akiyama H, Abe M, Miyazono K, Matsumoto T, Imamura T. 2009. Pin1 down-regulates transforming growth factor-β (TGF-β) signaling by inducing degradation of Smad proteins. J Biol Chem. 284:6109–6115.
   PubMed Web of Science ®Google Scholar
• Nakano N, Itoh S, Watanabe Y, Maeyama K, Itoh F, Kato M. 2010. Requirement of TCF7L2 for TGF-β-dependent transcriptional activation of the TMEPAI gene. J Biol Chem. 285:38023–38033.
   Google Scholar
• Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, ten Dijke P. 1997. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. Nature. 389:631–635.
   PubMed Web of Science ®Google Scholar
• Ogunjimi AA, Briant DJ, Pece-Barbara N, Le Roy C, Di Guglielmo GM, Kavsak P, Rasmussen RK, Seet BT, Sicheri F, Wrana JL. 2005. Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain. Mol Cell. 19:297–308.
   PubMed Web of Science ®Google Scholar
• Onichtchouk D, Chen Y-G, Dosch R, Gawantka V, Delius H, Massagué J, Niehrs C. 1999. Silencing of TGF-β signalling by the pseudoreceptor BAMBI. Nature. 401:480–485.
   PubMed Web of Science ®Google Scholar
• Pais H, Nicolas FE, Soond SM, Swingler TE, Clark IM, Chantry A, Moulton V, Dalmay T. 2010. Analyzing mRNA expression identifies Smad3 as a microRNA-140 target regulated only at protein level. RNA. 16:489–494.
   PubMed Web of Science ®Google Scholar
• Pan D, Estévez-Salmerón LD, Stroschein SL, Zhu X, He J, Zhou S, Luo K. 2005. The integral inner nuclear membrane protein MAN1 physically interacts with the R-Smad proteins to repress signaling by the transforming growth factor-β superfamily of cytokines. J Biol Chem. 280:15992–16001.
   PubMed Web of Science ®Google Scholar
• Pearce JJ, Penny G, Rossant J. 1999. A mouse cerberus/Dan-related gene family. Dev Biol. 209:98–110.
   PubMedGoogle Scholar
• Piccolo S, Sasai Y, Lu B, De Robertis EM. 1996. Dorsoventral patterning in Xenopus: Inhibition of ventral signals by direct binding of chordin to BMP-4. Cell. 86:589–598.
   PubMed Web of Science ®Google Scholar
• Reed JA, Bales E, Xu W, Okan NA, Bandyopadhyay D, Medrano EE. 2001. Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: Functional implications for transforming growth factor β signaling. Cancer Res. 61:8074–8078.
   PubMed Web of Science ®Google Scholar
• Remy I, Montmarquette A, Michnick SW. 2004. PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3. Nat Cell Biol. 6:358–365.
   PubMed Web of Science ®Google Scholar
• Robertson DM, Klein R, de Vos FL, McLachlan RI, Wettenhall RE, Hearn MT, Burger HG, de Kretser DM. 1987. The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin. Biochem Biophys Res Commun. 149:744–749.
   PubMed Web of Science ®Google Scholar
• Rogler CE, Levoci L, Ader T, Massimi A, Tchaikovskaya T, Norel R, Rogler LE. 2009. MicroRNA-23b cluster microRNAs regulate transforming growth factor-β/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology. 50:575–584.
   Google Scholar
• Sammar M, Stricker S, Schwabe GC, Sieber C, Hartung A, Hanke M, Oishi I, Pohl J, Minami Y, Sebald W, Mundlos S, Knaus P. 2004. Modulation of GDF5/BRI-b signalling through interaction with the tyrosine kinase receptor Ror2. Genes Cells. 9:1227–1238.
   PubMed Web of Science ®Google Scholar
• Sapkota G, Knockaert M, Alarcón C, Montalvo E, Brivanlou AH, Massagué J. 2006. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-β pathways. J Biol Chem. 281:40412–40419.
   PubMedGoogle Scholar
• Sapkota G, Alarcón C, Spagnoli FM, Brivanlou AH, Massagué J. 2007. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell. 25:441–454.
   PubMed Web of Science ®Google Scholar
• Sarker KP, Kataoka H, Chan A, Netherton SJ, Pot I, Huynh MA, Feng X, Bonni A, Riabowol K, Bonni S. 2008. ING2 as a novel mediator of transforming growth factor-β-dependent responses in epithelial cells. J Biol Chem. 283:13269–13279.
   Google Scholar
• Satow R, Kurisaki A, Chan T-C, Hamazaki TS, Asashima M. 2006. Dullard promotes degradation and dephosphorylation of BMP receptors and is required for neural induction. Dev Cell. 11:763–774.
   Google Scholar
• Schmierer B, Tournier AL, Bates PA, Hill CS. 2008. Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting system. Proc Natl Acad Sci U S A. 105:6608–6613.
   PubMed Web of Science ®Google Scholar
• Schultz N, Marenstein DR, De Angelis DA, Wang WQ, Nelander S, Jacobsen A, Marks DS, Massagué J, Sander C. 2011. Off-target effects dominate a large-scale RNAi screen for modulators of the TGF-β pathway and reveal microRNA regulation of TGFBR2. Silence. 14 2: 3.
   Google Scholar
• Semënov M, Tamai K, He X. 2005. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem. 280:26770–26775.
   PubMed Web of Science ®Google Scholar
• Seo SR, Lallemand F, Ferrand N, Pessah M, L'Hoste S, Camonis J, Atfi A. 2004. The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation. EMBO J. 23:3780–3792.
   PubMed Web of Science ®Google Scholar
• Seo SR, Ferrand N, Faresse N, Prunier C, Abécassis L, Pessah M, Bourgeade MF, Atfi A. 2006. Nuclear retention of the tumor suppressor cPML by the homeodomain protein TGIF restricts TGF-β signaling. Mol Cell. 23:547–559.
   PubMedGoogle Scholar
• Shi W, Sun C, He B, Xiong W, Shi X, Yao D, Cao X. 2004. GADD34-PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor. J Cell Biol. 164:291–300.
   PubMed Web of Science ®Google Scholar
• Singha PK, Yeh IT, Venkatachalam MA, Saikumar P. 2010. Transforming growth factor-β (TGF-β)-inducible gene TMEPAI converts TGF-β from a tumor suppressor to a tumor promoter in breast cancer. Cancer Res. 70:6377–6383.
   PubMed Web of Science ®Google Scholar
• Song K, Wang H, Krebs TL, Danielpour D. 2006. Novel roles of Akt and mTOR in suppressing TGF-β/ALK5-mediated Smad3 activation. EMBO J. 25:58–69.
   PubMed Web of Science ®Google Scholar
• Soond SM, Chantry A. 2011. Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT. Oncogene. 30:2451–2462.
   PubMed Web of Science ®Google Scholar
• Stroschein SL, Wang W, Zhou S, Zhou Q, Luo K. 1999. Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science. 286:771–774.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Raya A, Kawakami Y, Morita M, Matsui T, Nakashima K, Gage FH, Rodríguez-Esteban C, Izpisúa Belmonte JC. 2006. Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells. Proc Natl Acad Sci U S A. 103:10294–10299.
   PubMedGoogle Scholar
• van Bezooijen RL, Roelen BA, Visser A, van der Wee-Pals L, de Wilt E, Karperien M, Hamersma H, Papapoulos SE, ten Dijke P, Löwik CW. 2004. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med. 199:805–814.
   PubMed Web of Science ®Google Scholar
• Valdimarsdottir G, Goumans M-J, Itoh F, Itoh S, Heldin C-H, ten Dijke P. 2006. Smad7 and protein phosphatase 1a are critical determinants in the duration of TGF-β/ALK1 signaling in endothelial cells. BMC Cell Biol. 7:16.
   Google Scholar
• Wan M, Cao X, Wu Y, Bai S, Wu L, Shi X, Wang N, Cao X. 2002. Jab1 antagonizes TGF-β signaling by inducing Smad4 degradation. EMBO Rep. 3:171–176.
   PubMed Web of Science ®Google Scholar
• Wan M, Tang Y, Tytler EM, Lu C, Jin B, Vickers SM, Yang L, Shi X, Cao X. 2004. Smad4 protein stability is regulated by ubiquitin ligase SCFβ-TrCP1. J Biol Chem. 279:14484–14487.
   PubMed Web of Science ®Google Scholar
• Wang T, Li BY, Danielson PD, Shah PC, Rockwell S, Lechleider RJ, Martin J, Manganaro T, Donahoe PK. 1996. The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors. Cell. 86:435–444.
   PubMed Web of Science ®Google Scholar
• Wang Q, Huang Z, Xue H, Jin C, Ju XL, Han JD, Chen YG. 2008. MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood. 111:588–595.
   PubMed Web of Science ®Google Scholar
• Wang G, Matsuura I, He D, Liu F. 2009. Transforming growth factor-β-inducible phosphorylation of Smad3. J Biol Chem. 284:9663–9673.
   Google Scholar
• Wang B, Koh P, Winbanks C, Coughlan MT, McClelland A, Watson A, Jandeleit-Dahm K, Burns WC, Thomas MC, Cooper ME, Kantharidis P. 2011. miR-200a prevents renal fibrogenesis through repression of TGF-β2 expression. Diabetes. 60:280–287.
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Itoh S, Goto T, Ohnishi E, Inamitsu M, Itoh F, Satoh K, Wiercinska E, Yang W, Shi L, Tanaka A, Nakano N, Mommaas AM, Shibuya H, ten Dijke P, Kato M. 2010. TMEPAI, a transmembrane TGF-β-inducible protein, sequesters Smad proteins from active participation in TGF-β signaling. Mol Cell. 37:123–134.
   PubMed Web of Science ®Google Scholar
• Wotton D, Lo RS, Lee S, Massagué J. A Smad transcriptional corepressor. Cell. 1999a; 97:29–39.
   PubMed Web of Science ®Google Scholar
• Wotton D, Lo RS, Swaby LA, Massagué J. Multiple modes of repression by the Smad transcriptional corepressor TGIF. J Biol Chem. 1999b; 274:37105–37110.
   PubMedGoogle Scholar
• Wotton D, Knoepfler PS, Laherty CD, Eisenman RN, Massagué J. 2001. The Smad transcriptional corepressor TGIF recruits mSin3. Cell Growth Differ. 12:457–463.
   PubMedGoogle Scholar
• Wrighton KH, Willis D, Long J, Liu F, Lin X, Feng X-H. 2006. Small carboxy-terminal domain phosphatases dephosphorylate the regulatory linker regions of Smad2 and Smad3 to enhance TGF-β signaling. J Biol Chem. 281:38365–38375.
   PubMedGoogle Scholar
• Wu MY, Hill CS. 2009. TGF-β superfamily signaling in embryonic development and homeostasis. Dev Cell. 16:329–343.
   PubMed Web of Science ®Google Scholar
• Xin H, Xu X, Linyu L, Ning H, Rong Y, Shang Y, Wang Y, Fu X-Y, Chang Z. 2005. CHIP controls the sensitivity of transforming growth factor-β signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation. J Biol Chem. 280:20850–20942.
   Google Scholar
• Yan X, Chen YG. 2011. Smad7: Not only a regulator, but also a cross-talk mediator of TGF-β signalling. Biochem J. 434:1–10.
   PubMed Web of Science ®Google Scholar
• Yan X, Lin Z, Chen F, Zhao X, Chen H, Ning Y, Chen YG. 2009. Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-β signaling. J Biol Chem. 284:30097–30104.
   PubMedGoogle Scholar
• Yao G, Yin M, Lian J, Tian H, Liu L, Li X, Sun F. 2010. MicroRNA-224 is involved in transforming growth factor-β-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4. Mol Endocrinol. 24:540–551.
   PubMedGoogle Scholar
• Yu J, Pan L, Qin X, Chen H, Xu Y, Chen Y, Tang H. 2010. MTMR4 attenuates transforming growth factor β (TGFβ) signaling by dephosphorylating R-Smads in endosomes. J Biol Chem. 285:8454–8462.
   Google Scholar
• Yuan B, Dong R, Shi D, Zhou Y, Zhao Y, Miao M, Jiao B. 2011. Down-regulation of miR-23b may contribute to activation of the TGF-β1/Smad3 signalling pathway during the termination stage of liver regeneration. FEBS Lett. 585:927–934.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhou H, Su Y, Sun Z, Zhang H, Zhang L, Zhang Y, Ning Y, Chen Y-G, Meng A. 2004. Zebrafish Dpr2 inhibits mesoderm induction by promoting degradation of nodal receptors. Science. 306:114–117.
   Google Scholar
• Zhang S, Fei T, Zhang L, Zhang R, Chen F, Ning Y, Han Y, Feng XH, Meng A, Chen YG. 2007. Smad7 antagonizes transforming growth factor β signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol Cell Biol. 27:4488–4499.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Lu L, Zhou J, Li Y, Liu Y, Clemmons DR, Duan C. 2011. IGF binding protein 3 exerts its ligand-independent action by antagonizing BMP in zebrafish embryos. J Cell Sci. 124:1925–1935.
   Google Scholar
• Zimmerman LB, De Jesús-Escobar JM, Harland RM. 1996. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell. 86:599–606.
   PubMed Web of Science ®Google Scholar